Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

NDTDI

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
NDTDI
Legal status
Legal status
  • Illegal in Latvia
Identifiers
  • N,N-diethyl-3-(methyl(1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)amino)propanamide
PubChemCID
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC19H27N3O
Molar mass313.445 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)CCN(C)C1Cc3cccc2ncc(C1)c23
  • InChI=1S/C19H27N3O/c1-4-22(5-2)18(23)9-10-21(3)16-11-14-7-6-8-17-19(14)15(12-16)13-20-17/h6-8,13,16,20H,4-5,9-12H2,1-3H3
  • Key:JECGWOMOCPQHDH-UHFFFAOYSA-N

NDTDI is a tricyclictryptamine derivative which is thought to act as aserotonin receptor agonist, though its pharmacology has not been studied in detail. It is a structurally simplified analogue ofLSD and is reported to retain similar effects, though with many times lower potency. It has been sold as adesigner drug since 2016 and was first identified by a forensic laboratory in Slovenia in 2017.[1]

Legality

[edit]

NDTDI was made illegal in Latvia in March 2017.[2]

See also

[edit]

References

[edit]
  1. ^Analytical Report: NDTDI. Nacionalni Forenzični Laboratorij, Slovenia, June 2017
  2. ^Par aizlieguma noteikšanu vielai NDTDI un tās saturošiem izstrādājumiem.
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Tryptamines
N-Acetyltryptamines
α-Alkyltryptamines
Triptans
Cyclized tryptamines
Isotryptamines
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=NDTDI&oldid=1247000266"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp